MARC details
000 -LEADER |
fixed length control field |
01791nam a22002297a 4500 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
OSt |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20191226214707.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
110914t xxu||||| |||| 00| 0 eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9241562064 |
060 ## - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
Classification number |
QV 33 E 2002 |
100 1# - MAIN ENTRY--PERSONAL NAME |
Personal name |
Ratanawijitrasin, Sauwakon. |
9 (RLIN) |
4739 |
245 10 - TITLE STATEMENT |
Title |
Effective drug regulation a multicountry study. |
Statement of responsibility, etc. |
Sauwakon Ratanawijitrasin, Eshetu Wondemagegnehu. |
260 ## - PUBLICATION, DISTRIBUTION, ETC. |
Place of publication, distribution, etc. |
Geneva : |
Name of publisher, distributor, etc. |
World Health Organization, |
Date of publication, distribution, etc. |
2002. |
300 ## - PHYSICAL DESCRIPTION |
Extent |
ix, 142 p. : |
Other physical details |
ill. ; |
Dimensions |
30 cm. |
504 ## - BIBLIOGRAPHY, ETC. NOTE |
Bibliography, etc. note |
Includes bibliographical references (p. 141-142). |
520 ## - SUMMARY, ETC. |
Summary, etc. |
Drugs play a crucial role in saving lives, restoring health, and preventing diseases and epidemics. But they need to be safe, efficacious, of good quality, and used rationally. This means that their production, import/export, storage, supply and distribution should be subject to government control through prescribed norms and standards and an effective regulatory system. Substandard and counterfeit drugs proliferate primarily in an environment where drug regulation has proved ineffective.<br/><br/>This publication presents a synthesis of studies on drug regulation carried out in 10 countries: Australia, Cuba, Cyprus, Estonia, Malaysia, the Netherlands, Tunisia, Uganda, Venezuela, and Zimbabwe in 1998-1999. It gives an overview of the development of drug regulation in these countries as well as the resources available and the strategies applied in drug regulation implementation at the time the studies were conducted. An analysis of the strengths and weaknesses in drug regulation in these countries is also provided. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Pharmaceutical policy |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Drugs |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Wondemagegnehu, Eshetu. |
9 (RLIN) |
4742 |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Source of classification or shelving scheme |
National Library of Medicine Classification |
Koha item type |
WHO Publications |